As filed with the Securities and Exchange Commission on November 22, 2002.
Registration No. 333-91228
================================================================================
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
-------------------
Post-Effective Amendment No. 3
filed pursuant to Rule 462(d) to
FORM S-3
REGISTRATION STATEMENT
UNDER
THE SECURITIES ACT OF 1933
--------------------
THE DOW CHEMICAL COMPANY
(Exact name of registrant as specified in its charter)
Delaware 38-1285128
(State or other jurisdiction of (I.R.S. Employer Identification No.)
incorporation or organization)
2030 Dow Center
Midland, Michigan 48674
(989) 636-1000
(Address, including zip code, and telephone, including number, including area
code, of registrant's principal executive offices)
Tina Van Dam
Corporate Secretary
The Dow Chemical Company
2030 Dow Center
Midland, Michigan 48674
(989) 636-1000
(Name, address, including zip code, and telephone number, including area code,
of agent for service)
----------------------
A copy to:
Edward S. Best
Mayer, Brown, Rowe & Maw
190 South LaSalle Street
Chicago, Illinois 60603
(312) 782-0600
----------------------
Approximate date of commencement of proposed sale to the public: From time
to time after the effective date of this Registration Statement.
If the only securities being registered on this Form are being offered
pursuant to dividend or interest reinvestment plans, please check the following
box. [_]
If any of the securities being registered on this Form are to be offered on
a delayed or continuous basis pursuant to Rule 415 under the Securities Act of
1933, other than securities offered only in connection with dividend or interest
reinvestment plans, check the following box. [X]
If this Form is filed to register additional securities for an offering
pursuant to Rule 462(b) under the Securities Act, please check the following box
and list the Securities Act registration statement number of the earlier
effective registration statement for the same offering. [_]
If this Form is a post-effective amendment filed pursuant to Rule 462(c)
under the Securities Act, check the following box and list the Securities Act
registration statement number of the earlier effective registration statement
for the same offering. [_]
If delivery of the prospectus is expected to be made pursuant to Rule 434,
please check the following box. [_]
EXPLANATORY NOTE
This Post-Effective Amendment No. 3 to the Registration Statement on Form
S-3 (File No. 333-91228) of The Dow Chemical Company is filed pursuant to Rule
462(d) solely to add certain exhibits not previously filed with respect to the
Registration Statement.
II-1
PART II -- INFORMATION NOT REQUIRED IN PROSPECTUS
Item 16. Exhibits
Exhibit
Number Description
------ -----------
1.3 Underwriting Agreement, dated as of November 18, 2002,
among The Dow Chemical Company, UBS Warburg LLC, ABN
AMRO Incorporated, Dresdner Kleinwort Wasserstein--
Grantchester, Inc., Barclays Capital Inc., BNP Paribas
Securities Corp., Commerzbank Capital Markets Corp.,
Daiwa Securities SMBC Europe Limited and RBC Dominion
Securities Corporation.
4.11 Form of Global Note for 5% Notes due 2007
5.4 Opinion of Charles J. Kalil, Assistant General Counsel
of Dow
23.6 Consent of Charles J. Kalil (included in Exhibit 5.3)
All of the foregoing exhibits are filed herewith.
II-2
SIGNATURES
Pursuant to the requirements of the Securities Act of 1933, the
registrant certifies that it has reasonable grounds to believe that it meets
all of the requirements for filing on Form S-3 and has duly caused this
post-effective amendment to the registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the County of Midland,
State of Michigan, on November 22, 2002.
THE DOW CHEMICAL COMPANY
By: /s/ Frank H. Brod
-----------------------------
Frank H. Brod
Vice President and Controller
Pursuant to the requirements of the Securities Act of 1933, this
post-effective amendment to the registration statement has been signed by the
following persons in the capacities indicated on November 22, 2002:
Director, President and Chief Executive Officer
* (principal executive officer)
------------------------------
M. D. Parker
Director, Executive Vice President and Chief Financial
* Officer (principal financial officer)
------------------------------
J. P. Reinhard
Vice President and Controller (Principal Accounting
* Officer)
------------------------------
F. H. Brod
* Director and Executive Vice President
------------------------------
A. A. Allemang
* Director
------------------------------
J. K. Barton
* Director and Vice Chairman of the Board
------------------------------
A. J. Carbone
* Director
------------------------------
J. M. Cook
* Director
------------------------------
J. C. Danforth
* Director
------------------------------
W. D. Davis
* Director
------------------------------
B. H. Franklin
* Director
------------------------------
J. M. Ringler
* Director
------------------------------
H. T. Shapiro
* Director and Chairman of the Board
------------------------------
W. S. Stavropoulos
* Director
------------------------------
P. G. Stern
* By: /s/ Frank H. Brod
------------------------------
Frank H. Brod
Attorney-in-Fact
EXHIBIT INDEX
Exhibit
Number Description
------- -----------
1.3 Underwriting Agreement, dated as of November 18, 2002,
among The Dow Chemical Company, UBS Warburg LLC, ABN AMRO
Incorporated, Dresdner Kleinwort Wasserstein--Grantchester,
Inc., Barclays Capital Inc., BNP Paribas Securities Corp.,
Commerzbank Capital Markets Corp., Daiwa Securities SMBC
Europe Limited and RBC Dominion Securities Corporation.
4.11 Form of Global Note for 5% Notes due 2007
5.4 Opinion of Charles J. Kalil, Assistant General Counsel of Dow
23.6 Consent of Charles J. Kalil (included in Exhibit 5.3)